United States Lyme Disease Vaccine Market Report 2017

December 2017 | 103 pages | ID: UABCD74358EEN
QYResearch

Abstracts

In this report, the United States Lyme Disease Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Lyme Disease Vaccine in these regions, from 2012 to 2022 (forecast).

United States Lyme Disease Vaccine market competition by top manufacturers/players, with Lyme Disease Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merck
• Merial
• Zoetis

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Inactivated Vaccine
• Attenuated Vaccine

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Scientific Research
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Lyme Disease Vaccine Market Report 2017

1 LYME DISEASE VACCINE OVERVIEW

1.1 Product Overview and Scope of Lyme Disease Vaccine
1.2 Classification of Lyme Disease Vaccine by Product Category
  1.2.1 United States Lyme Disease Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Lyme Disease Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Inactivated Vaccine
  1.2.4 Attenuated Vaccine
1.3 United States Lyme Disease Vaccine Market by Application/End Users
  1.3.1 United States Lyme Disease Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Scientific Research
  1.3.4 Others
1.4 United States Lyme Disease Vaccine Market by Region
  1.4.1 United States Lyme Disease Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Lyme Disease Vaccine Status and Prospect (2012-2022)
  1.4.3 Southwest Lyme Disease Vaccine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Lyme Disease Vaccine Status and Prospect (2012-2022)
  1.4.5 New England Lyme Disease Vaccine Status and Prospect (2012-2022)
  1.4.6 The South Lyme Disease Vaccine Status and Prospect (2012-2022)
  1.4.7 The Midwest Lyme Disease Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Lyme Disease Vaccine (2012-2022)
  1.5.1 United States Lyme Disease Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 United States Lyme Disease Vaccine Revenue and Growth Rate (2012-2022)

2 UNITED STATES LYME DISEASE VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Lyme Disease Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Lyme Disease Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Lyme Disease Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Lyme Disease Vaccine Market Competitive Situation and Trends
  2.4.1 United States Lyme Disease Vaccine Market Concentration Rate
  2.4.2 United States Lyme Disease Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Lyme Disease Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES LYME DISEASE VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Lyme Disease Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Lyme Disease Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Lyme Disease Vaccine Price by Region (2012-2017)

4 UNITED STATES LYME DISEASE VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Lyme Disease Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Lyme Disease Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Lyme Disease Vaccine Price by Type (2012-2017)
4.4 United States Lyme Disease Vaccine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES LYME DISEASE VACCINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Lyme Disease Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Lyme Disease Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES LYME DISEASE VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Merck
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Lyme Disease Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck Lyme Disease Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merial
  6.2.2 Lyme Disease Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merial Lyme Disease Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Zoetis
  6.3.2 Lyme Disease Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Zoetis Lyme Disease Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview

7 LYME DISEASE VACCINE MANUFACTURING COST ANALYSIS

7.1 Lyme Disease Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Lyme Disease Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Lyme Disease Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Lyme Disease Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES LYME DISEASE VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Lyme Disease Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Lyme Disease Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Lyme Disease Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Lyme Disease Vaccine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Lyme Disease Vaccine
Figure United States Lyme Disease Vaccine Market Size (K Pcs) by Type (2012-2022)
Figure United States Lyme Disease Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Inactivated Vaccine Product Picture
Figure Attenuated Vaccine Product Picture
Figure United States Lyme Disease Vaccine Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Lyme Disease Vaccine by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Scientific Research Examples
Table Key Downstream Customer in Scientific Research
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Lyme Disease Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Lyme Disease Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Lyme Disease Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Lyme Disease Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Lyme Disease Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Lyme Disease Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Lyme Disease Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Lyme Disease Vaccine Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Lyme Disease Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Lyme Disease Vaccine Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Lyme Disease Vaccine Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Lyme Disease Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Lyme Disease Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Lyme Disease Vaccine Sales Share by Players/Suppliers
Figure United States Lyme Disease Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Lyme Disease Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Lyme Disease Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Lyme Disease Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Lyme Disease Vaccine Revenue Share by Players/Suppliers
Table United States Market Lyme Disease Vaccine Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Lyme Disease Vaccine Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Lyme Disease Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Lyme Disease Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Lyme Disease Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Lyme Disease Vaccine Product Category
Table United States Lyme Disease Vaccine Sales (K Pcs) by Region (2012-2017)
Table United States Lyme Disease Vaccine Sales Share by Region (2012-2017)
Figure United States Lyme Disease Vaccine Sales Share by Region (2012-2017)
Figure United States Lyme Disease Vaccine Sales Market Share by Region in 2016
Table United States Lyme Disease Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Lyme Disease Vaccine Revenue Share by Region (2012-2017)
Figure United States Lyme Disease Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Lyme Disease Vaccine Revenue Market Share by Region in 2016
Table United States Lyme Disease Vaccine Price (USD/Pcs) by Region (2012-2017)
Table United States Lyme Disease Vaccine Sales (K Pcs) by Type (2012-2017)
Table United States Lyme Disease Vaccine Sales Share by Type (2012-2017)
Figure United States Lyme Disease Vaccine Sales Share by Type (2012-2017)
Figure United States Lyme Disease Vaccine Sales Market Share by Type in 2016
Table United States Lyme Disease Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Lyme Disease Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Lyme Disease Vaccine by Type (2012-2017)
Figure Revenue Market Share of Lyme Disease Vaccine by Type in 2016
Table United States Lyme Disease Vaccine Price (USD/Pcs) by Types (2012-2017)
Figure United States Lyme Disease Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Lyme Disease Vaccine Sales (K Pcs) by Application (2012-2017)
Table United States Lyme Disease Vaccine Sales Market Share by Application (2012-2017)
Figure United States Lyme Disease Vaccine Sales Market Share by Application (2012-2017)
Figure United States Lyme Disease Vaccine Sales Market Share by Application in 2016
Table United States Lyme Disease Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Lyme Disease Vaccine Sales Growth Rate by Application (2012-2017)
Table Merck Basic Information List
Table Merck Lyme Disease Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Lyme Disease Vaccine Sales Growth Rate (2012-2017)
Figure Merck Lyme Disease Vaccine Sales Market Share in United States (2012-2017)
Figure Merck Lyme Disease Vaccine Revenue Market Share in United States (2012-2017)
Table Merial Basic Information List
Table Merial Lyme Disease Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merial Lyme Disease Vaccine Sales Growth Rate (2012-2017)
Figure Merial Lyme Disease Vaccine Sales Market Share in United States (2012-2017)
Figure Merial Lyme Disease Vaccine Revenue Market Share in United States (2012-2017)
Table Zoetis Basic Information List
Table Zoetis Lyme Disease Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Zoetis Lyme Disease Vaccine Sales Growth Rate (2012-2017)
Figure Zoetis Lyme Disease Vaccine Sales Market Share in United States (2012-2017)
Figure Zoetis Lyme Disease Vaccine Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Lyme Disease Vaccine
Figure Manufacturing Process Analysis of Lyme Disease Vaccine
Figure Lyme Disease Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Lyme Disease Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Lyme Disease Vaccine
Table Distributors/Traders List
Figure United States Lyme Disease Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Lyme Disease Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Lyme Disease Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Lyme Disease Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Lyme Disease Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Lyme Disease Vaccine Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Lyme Disease Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Lyme Disease Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Lyme Disease Vaccine Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Lyme Disease Vaccine Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Lyme Disease Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Lyme Disease Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Lyme Disease Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources